|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.680 USD | -0.62% |
|
+0.73% | +57.40% |
| 05-15 | ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026 | |
| 05-15 | ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Scours | - | 18.41M | 17.29M | 26.31M | 27.45M | |||||
Total Assets | - | 20.54M | 24.74M | 24.64M | 38.25M | |||||
CAPEX | - | -3.51M | -1.1M | -410K | -1.17M | |||||
Gross Profit | - | 7.66M | 3.84M | 7.93M | 11.42M | |||||
D&A | - | 1.17M | 1.37M | 1.37M | 1.46M | |||||
Operating Income | - | 5.72M | 1.38M | 4.78M | 7.89M | |||||
Mastitis | - | 155K | 178K | 179K | 196K | |||||
Total Assets | - | 18.32M | 17.83M | 16.52M | 134K | |||||
CAPEX | - | -414K | -796K | -53.72K | -74.88K | |||||
Gross Profit | - | 18.21K | 28.86K | 9.74K | 27.26K | |||||
D&A | - | 1.26M | 1.29M | 1.28M | 1.26M | |||||
Operating Income | - | -5.62M | -4.85M | -4.04M | -2.92M | |||||
Biotechnology | 19.24M | - | - | - | - | |||||
Total Assets | 44.47M | - | - | - | - | |||||
Interest Expense | -314K | - | - | - | - | |||||
Income Tax Expense | 9.16K | - | - | - | - | |||||
CAPEX | -2.61M | - | - | - | - | |||||
EBT | -69.13K | - | - | - | - | |||||
Gross Profit | 8.66M | - | - | - | - | |||||
D&A | 2.46M | - | - | - | - | |||||
Operating Income | 257K | - | - | - | - | |||||
Net Income | -78.29K | - | - | - | - | |||||
Other | - | 1.46K | - | - | - | |||||
Total Assets | - | 6.01M | 1.24M | 3.93M | 4.15M | |||||
CAPEX | - | -47.45K | - | -2.31K | -7.13K | |||||
Gross Profit | - | -27.19K | - | - | - | |||||
D&A | - | 62.91K | 86.03K | 78.81K | 69.25K | |||||
Operating Income | - | -2.4M | -2.28M | -2.38M | -3.32M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 16.62M | 17.02M | 15.95M | 22.89M | 24.39M | |||||
Other | 2.62M | 1.55M | 1.52M | 3.6M | 3.25M |
- Stock Market
- Stocks
- ICCC Stock
- Financials ImmuCell Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
